| ASSET | YEAR | % RETURN |
|---|---|---|
Envela (ELA) | 1991 | 990.91% |
BioLife Solutions (BLFS) | 1991 | 765.98% |
Oppenheimer (OPY) | 1991 | 418.2% |
Mesa Laboratories (MLAB) | 1991 | 383.31% |
National HealthCare (NHC) | 1991 | 335.93% |
STAAR Surgical (STAA) | 1991 | 306.95% |
Celldex Therapeutics (CLDX) | 1991 | 266.67% |
Hovnanian Enterprises (HOV) | 1991 | 265.22% |
ODP (ODP) | 1991 | 223.2% |
Axogen (AXGN) | 1991 | 217.86% |
CONMED (CNMD) | 1991 | 195.65% |
Universal (UVV) | 1991 | 189.37% |
Digi International (DGII) | 1991 | 168.29% |
Tat Techno (TATT) | 1991 | 162.67% |
Lindsay (LNN) | 1991 | 156.81% |
Cracker Barrel Old Country Store (CBRL) | 1991 | 155.86% |
Great Southern Bancorp (GSBC) | 1991 | 144.9% |
Natures Sunshine Products (NATR) | 1991 | 144.5% |
Benchmark Electronics (BHE) | 1991 | 134.14% |
Matrix Service (MTRX) | 1991 | 131.82% |
Oxford Industries (OXM) | 1991 | 130.64% |
Astronics (ATRO) | 1991 | 110.92% |
Transcontinental Realty Investors (TCI) | 1991 | 104.67% |
Xerox (XRX) | 1991 | 102.5% |
Astec Industries (ASTE) | 1991 | 99.99% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
